Collaboration between the NHS Accelerated Access Collaborative, AstraZeneca and the Oxford AHSN has resulted in the development of SPECTRA, a suite of clinical audit tools to support the identification of uncontrolled asthma patients in primary care. Find out more about SPECTRA in this webinar.
Date: 18th January 2022
Presented in conjunction with Dr Michael Crooks (Hull & East Yorkshire Teaching Hospitals NHS Trust) and Astrazeneca. This session is free to staff from NHS organisations and those working within the AHSN Networks.
Date: 1st December 2021.
Asthma Biologics Leads
There are 15 AHSN Asthma Biologic leads across England taking part in the Asthma Biologics programme.
You can contact those leads using the details below
|AHSN||Asthma Biologics Lead||Asthma Biologics Lead Email|
|Kent, Surrey and Sussex||Hinal Patelfirstname.lastname@example.org|
|East Midlands||Karen Chappellemail@example.com|
|West Midlands||Helen Huntfirstname.lastname@example.org|
|South West||Steve Johnson-Woodemail@example.com|
|West of England||Clare Evans||Clare.Evans14@nhs.net|
|Yorkshire and Humber||Harriett Smithfirstname.lastname@example.org|
|Health Innovation Network||Dominic Nortonemail@example.com|
|North East and North Cumbria||Rachel Morrisfirstname.lastname@example.org|
|Health Innovation Manchester||Binita Kaneemail@example.com|
|Imperial College||Logan Ryan||Logan.Ryan@imperialcollegehealthpartners.com|
|Innovation Agency North West Coast||Julia Reynoldsfirstname.lastname@example.org|